Hongjin Li1, Crystal L Patil2, Robert E Molokie3,4,5, Franklin Njoku3, Alana D Steffen6, Ardith Z Doorenbos1, Judith M Schlaeger2. 1. Department of Biobehavioral Nursing Science, College of Nursing, University of Illinois at Chicago, Chicago, IL, USA. 2. Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL, USA. 3. Department of Hematology/Oncology, College of Medicine, University of Illinois Chicago, Chicago, IL, USA. 4. Jesse Brown Veterans Administration Medical Center, Chicago, IL, USA. 5. Department of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, IL, USA. 6. Department of Population Health Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL, USA.
Abstract
OBJECTIVE: Chronic pain is a common symptom experienced among patients with sickle cell disease (SCD). Our aims were to assess the feasibility and acceptability of performing acupuncture for the treatment of chronic pain in adults with SCD. METHODS: This was a single-arm, prospective pilot study of six adults with SCD. Participants reported ⩾ 3 months of chronic pain and were > 18 years of age. Per protocol, acupuncture was to be administered twice per week for 5 weeks, for 30 min per session. All treatments were performed in the acupuncture treatment laboratory at the University of Illinois Chicago College of Nursing. Pain intensity, pain interference, and other symptoms were measured at baseline and after the intervention. Participants completed a semi-structured interview and a protocol acceptability questionnaire after the acupuncture intervention. RESULTS: Six participants (mean age 52.5 years, six Black) were enrolled. Although the study was suspended due to COVID-19 and not all participants completed the 10-session protocol, completion rates were high with no missed appointments. One participant did not complete the study due to hospitalization unrelated to acupuncture. No adverse events were reported. At completion of the intervention at 4-5 weeks post-baseline, all participants had reduced pain intensity and pain interference. The mean acceptability score on the protocol acceptability questionnaire was 82%. CONCLUSION: It was feasible and acceptable to implement acupuncture in adults with SCD. This study can be used to guide a larger randomized controlled trial to evaluate the effect of acupuncture on reducing chronic pain in adults with SCD.Trial registration number: NCT04156399 (ClinicalTrials.gov).
OBJECTIVE: Chronic pain is a common symptom experienced among patients with sickle cell disease (SCD). Our aims were to assess the feasibility and acceptability of performing acupuncture for the treatment of chronic pain in adults with SCD. METHODS: This was a single-arm, prospective pilot study of six adults with SCD. Participants reported ⩾ 3 months of chronic pain and were > 18 years of age. Per protocol, acupuncture was to be administered twice per week for 5 weeks, for 30 min per session. All treatments were performed in the acupuncture treatment laboratory at the University of Illinois Chicago College of Nursing. Pain intensity, pain interference, and other symptoms were measured at baseline and after the intervention. Participants completed a semi-structured interview and a protocol acceptability questionnaire after the acupuncture intervention. RESULTS: Six participants (mean age 52.5 years, six Black) were enrolled. Although the study was suspended due to COVID-19 and not all participants completed the 10-session protocol, completion rates were high with no missed appointments. One participant did not complete the study due to hospitalization unrelated to acupuncture. No adverse events were reported. At completion of the intervention at 4-5 weeks post-baseline, all participants had reduced pain intensity and pain interference. The mean acceptability score on the protocol acceptability questionnaire was 82%. CONCLUSION: It was feasible and acceptable to implement acupuncture in adults with SCD. This study can be used to guide a larger randomized controlled trial to evaluate the effect of acupuncture on reducing chronic pain in adults with SCD.Trial registration number: NCT04156399 (ClinicalTrials.gov).
Authors: Hugh MacPherson; Douglas G Altman; Richard Hammerschlag; Li Youping; Wu Taixiang; Adrian White; David Moher Journal: J Altern Complement Med Date: 2010-10 Impact factor: 2.579
Authors: Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Veronica Angulo; Diana J Wilkie Journal: J Pain Symptom Manage Date: 2014-03-15 Impact factor: 3.612
Authors: D J Wilkie; H Y Huang; D L Berry; A Schwartz; Y C Lin; N Y Ko; A Chen; J Gralow; S K Lindsley; D Fitzgibbon Journal: Fam Community Health Date: 2001-10
Authors: Dagmar Amtmann; Karon F Cook; Mark P Jensen; Wen-Hung Chen; Seung Choi; Dennis Revicki; David Cella; Nan Rothrock; Francis Keefe; Leigh Callahan; Jin-Shei Lai Journal: Pain Date: 2010-07 Impact factor: 6.961
Authors: Gwenyth R Wallen; Caterina P Minniti; Michael Krumlauf; Ellen Eckes; Darlene Allen; Anna Oguhebe; Cassie Seamon; Deepika S Darbari; Mariana Hildesheim; Li Yang; Jeffrey D Schulden; Gregory J Kato; James G Taylor Journal: BMC Psychiatry Date: 2014-07-21 Impact factor: 3.630
Authors: Rachel L Richesson; Keith S Marsolo; Brian J Douthit; Karen Staman; P Michael Ho; Dana Dailey; Andrew D Boyd; Kathleen M McTigue; Miriam O Ezenwa; Judith M Schlaeger; Crystal L Patil; Keturah R Faurot; Leah Tuzzio; Eric B Larson; Emily C O'Brien; Christina K Zigler; Joshua R Lakin; Alice R Pressman; Jordan M Braciszewski; Corita Grudzen; Guilherme Del Fiol Journal: J Am Med Inform Assoc Date: 2021-11-25 Impact factor: 4.497